Immunotech
Patent Owner
Stats
- 13 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Feb 03, 2004 most recent publication
Details
- 13 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 224 Total Citation Count
- Sep 18, 1985 Earliest Filing
- 4 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6534279 Reagent and method for the permeabilization and identification of erythrocytesJun 23, 99Mar 18, 03[G01N]
5817468 Process for the identification or immunoassay of polypeptide antigensDec 23, 96Oct 06, 98[G01N, C07K]
5723309 Production of subunits of soluble T cell receptors by co-transfectionSep 14, 94Mar 03, 98[C12N]
5599682 Method for the protection of leucocytes and method of blood analysisMay 19, 94Feb 04, 97[G01N]
5559012 Therapeutic, IL-6 antibody kits, and process for their preparationJul 25, 94Sep 24, 96[C12P, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
6326401 Formulation for the oromucosal, in particular pernasal, routeExpiredJan 06, 99Dec 04, 01[A61K]
5116724 Products for separation applicable to cells in the immunopurification fieldExpiredSep 29, 88May 26, 92[C12N, A61B]
4670543 Process for obtaining complex FVIII/vWF of therapeutical use and resulting productsExpiredSep 18, 85Jun 02, 87[C07G]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.